REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/06/2025
Voltar para busca
Dado oficial do USPTO
HY·TISSUE SVF
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
10/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
07/06/2018
Data de registro
09/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/06/2020
Última transação
10/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
09
Localização do titular
IT
Examinador
CIANCI, RYAN
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "HY TISSUE SVF". A middle dot appears between "HY" and "TISSUE". The wording "SVF" is shaded.
Titulares e representantes
Titulares
FIDIA FARMACEUTICI S.p.A.
Representantes
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of woundsburnsulcersdamaged skin and tissuejoint and musculo-skeletal diseases and disorders; Pharmaceutical preparationshuman allograft tissue; blood plasma; anticoagulants; diagnostic preparations for medical purposes; human tissues to be used in allografts; surgical implants comprising living tissues; biological skin tissues intended for subsequent implantation; organic tissue cultures for medical purposes; surgical implants comprised of living tissues; gauzes for medical purposes; gauzes for dressings; adhesive bands for medical use; dressingsmedical; adhesive bandages; wound dressings; disinfectant dressings; sterilized dressings; medicated compresses; applicatorscotton swabs for medical use; surgical gauzes
Classe 10
Medical devices for the treatment of woundsburnsulcersdamaged skin and tissuejoint and musculo-skeletal diseases and disorders; Surgical instruments and apparatus; medical apparatus for the preparation and injection of stromal vascular fraction (SVF) cells; medical apparatus and instruments for separating human and animal tissues and cells; dispersion medical devices for dispersing biological material for preparing cellular suspensions and micro-insert of tissue; medical equipment used in microbiological laboratories for processing biological material; apparatus for medical laboratories for treating tissue samples; medical devices for the care of diseases concerning human tissue and for mixing veterinary medicine; blood testing apparatus; cannulas; catheters; hemocytometers; injection needles; glass capillary tubes for medical purposes; centrifuges for medical use; kit consisting of apparatus for collection and separation of tissues and their implant for medical purposes; applicators and devicesmedical injection devices for the administration of pharmaceuticalcosmetic and dermocosmetic drug preparations; bags for endoscopic tissue recoverymedical bags designed to hold tissue; biodegradable implants comprising naturalnon-living materials; medical ultrasonic vacuum cleaners for the separation of soft tissue parts; needles for medical purposes; needles for injection; syringes for surgical use; syringes for medical use; hypodermic syringes; inflation syringes for medical or surgical use; caps for medical syringes; connectors for medical syringes; scalpels; blades for scalpels for surgical purposes; sacs and sachetsmedical bags adapted for surgical and medical use; blood isolation bags for medical use; medical bags for the collection of body fluids; blood suction bags for medical use; medical bags for collecting wound drainage; medical bags for the collection of body waste; medical bags and medical pouches for collecting body waste with filtering membranes for medical and surgical use; filters and filtering membranesblood filters for medical purposes; acupuncture tools
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/11/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/10/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
02/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/03/2020
PUBO
PUBLISHED FOR OPPOSITION
24/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/02/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
30/01/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
13/08/2019
GNFR
FINAL REFUSAL E-MAILED
13/08/2019
CNFR
FINAL REFUSAL WRITTEN
13/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/07/2019
RFNT
REFUSAL PROCESSED BY IB
16/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/01/2019
RFRR
REFUSAL PROCESSED BY MPU
30/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
19/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/01/2019
CNRT
NON-FINAL ACTION WRITTEN
17/01/2019
DOCK
ASSIGNED TO EXAMINER
15/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/01/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HY·TISSUE SVF ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.